** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39
** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34
** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption
** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co
** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.